Endocrinology, Diabetes & Metabolism Case Reports (Apr 2021)

Atypical progeroid syndrome (p.E262K LMNA mutation): a rare cause of short stature and osteoporosis

  • Marina Yukina,
  • Nurana Nuralieva,
  • Ekaterina Sorkina,
  • Ekaterina Troshina,
  • Anatoly Tiulpakov,
  • Zhanna Belaya,
  • Galina Melnichenko

DOI
https://doi.org/10.1530/EDM-20-0188
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 9

Abstract

Read online

Lamin A/C (LMNA) gene mutations cause a heterogeneous group of progeroid disorders, including Hutchinson–Gilford progeria syndrome, mandibuloacral dysplasia, atypical progeroid syndrome (APS) and generalized lipodystrophy-associated progeroid syndrome (GLPS). All of those syndromes are associated with some progeroid features, lipodystrophy and metabolic complications but vary differently depending on a particular mutation and even patients carrying the same gene variant are known to have clinical heterogeneity. We report a new 30-year-old female patient from Russia with an APS and generalized lipodystrophy (GL) due to the heterozygous de novo LMNA p.E262K mutation and compare her clinical and metabolic features to those of other described patients with APS. Despite many health issues, short stature, skeletal problems, GL and late diagnosis of APS, our patient seems to be relatively metabolically healthy for her age when compared to previously described patients with APS.